Novel Technology Commercialization

Blazing a trail isn’t easy, but that’s not why you’re doing it. Navigating strategy for novel technologies and creating new, uncharted markets requires creativity, innovation, and experience. We’re here to help.

Our Experts

Stephane Budel

Miguel Edwards

Andrew Aijian

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Financial Services

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.

View

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Clinical Diagnostics

Longitudinal Monitoring of Cancer Early Detection Market

A top-10 diagnostics player wanted to monitor market development activities and competitive intelligence in the early cancer detection space

View

Competitive Analysis

Clinical Diagnostics

NIPT Market Landscape and Strategy

A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.

View

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Go-to-Market Strategy

Research Tools

VOC research, competitive assessment for a novel multi-omic technology

A ~$100M research tools and diagnostic company wanted to understand key applications and revenue potential of their novel technology to inform a go / no-go development decision

View

Pricing Strategy

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Novel Technology Commercialization

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

View

Voice-of-Customer Research

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

View

Target Identification

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch